Anna Lebedeva1, Elena Maryukhnich1, Jean-Charles Grivel2, Elena Vasilieva1, Leonid Margolis3, Alexander Shpektor1. 1. Laboratory of Atherothrombosis, Moscow State University of Medicine and Dentistry, Moscow, Russia. 2. Sidra Medical and Research Center, Doha, Qatar. 3. Section on Intercellular Interactions, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md. Electronic address: margolil@mail.nih.gov.
Abstract
BACKGROUND: An association between productive cytomegalovirus infection and atherosclerosis was shown recently in several trials, including a previous study of ours. However, the mechanism involved in this association is still under investigation. Here, we addressed the interaction between productive cytomegalovirus infection and endothelial function in patients with ST-elevation myocardial infarction (STEMI). METHODS: We analyzed the presence of cytomegaloviral DNA in plasma and endothelial function in 33 patients with STEMI and 33 volunteers without cardiovascular diseases, using real-time polymerase chain reaction (PCR) and a noninvasive test of flow-mediated dilation. RESULTS: Both the frequency of presence and the load of cytomegaloviral DNA were higher in plasma of patients with STEMI than those in controls. This difference was independent of other cardiovascular risk factors (7.38 [1.36-40.07]; P = 0.02). The results of the flow-mediated dilation test were lower in patients in STEMI than in controls (5.0% [2.65%-3.09%] vs 12. %5 [7.5%-15.15%]; P = 0.004) and correlated negatively with the cytomegaloviral DNA load (Spearman R = -0.407; P = 0.019) independently of other cardiovascular risk factors. CONCLUSIONS: Productive cytomegalovirus infection in patients with STEMI correlated negatively with endothelial function independently of other cardiovascular risk factors. The impact of cytomegalovirus on endothelial function may explain the role of cytomegalovirus in cardiovascular prognosis. Published by Elsevier Inc.
BACKGROUND: An association between productive cytomegalovirus infection and atherosclerosis was shown recently in several trials, including a previous study of ours. However, the mechanism involved in this association is still under investigation. Here, we addressed the interaction between productive cytomegalovirus infection and endothelial function in patients with ST-elevation myocardial infarction (STEMI). METHODS: We analyzed the presence of cytomegaloviral DNA in plasma and endothelial function in 33 patients with STEMI and 33 volunteers without cardiovascular diseases, using real-time polymerase chain reaction (PCR) and a noninvasive test of flow-mediated dilation. RESULTS: Both the frequency of presence and the load of cytomegaloviral DNA were higher in plasma of patients with STEMI than those in controls. This difference was independent of other cardiovascular risk factors (7.38 [1.36-40.07]; P = 0.02). The results of the flow-mediated dilation test were lower in patients in STEMI than in controls (5.0% [2.65%-3.09%] vs 12. %5 [7.5%-15.15%]; P = 0.004) and correlated negatively with the cytomegaloviral DNA load (Spearman R = -0.407; P = 0.019) independently of other cardiovascular risk factors. CONCLUSIONS: Productive cytomegalovirus infection in patients with STEMI correlated negatively with endothelial function independently of other cardiovascular risk factors. The impact of cytomegalovirus on endothelial function may explain the role of cytomegalovirus in cardiovascular prognosis. Published by Elsevier Inc.
Authors: Mikhail V Khoretonenko; Igor L Leskov; Stephen R Jennings; Andrew D Yurochko; Karen Y Stokes Journal: Am J Pathol Date: 2010-08-27 Impact factor: 4.307
Authors: John F Carlquist; Joseph B Muhlestein; Benjamin D Horne; Noal I Hart; Tobin Lim; Jessica Habashi; Jeffrey G Anderson; Jeffrey L Anderson Journal: Atherosclerosis Date: 2004-11 Impact factor: 5.162
Authors: Richard Ahn; Joanna Schaenman; Zachary Qian; Harry Pickering; Victoria Groysberg; Maura Rossetti; Megan Llamas; Alexander Hoffmann; David Gjertson; Mario Deng; Suphamai Bunnapradist; Elaine F Reed Journal: Front Immunol Date: 2021-11-15 Impact factor: 7.561